# US 9,750,838 B2 · Wound management system and methods of using > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 9,750,838 B2 - Document ID: US9750838B2 - Status: Granted - Kind: B2 - Application number: 14/664,264 - Filed: 2015-03-20 - Published: 2015-09-24 - Granted: 2017-09-05 - Earliest claimed: 2014-03-21 - Assignees: Medline Industries, Inc. - Applicants: Medline Industries, Inc. - Inventors: Angie Duncan; Bridget Donovan; Debashish Chakravarthy; Maria Miller - Web page: https://patentgrep.com/patent/US9750838B2 ## CPC - A61L 15/42: Use of materials characterised by their function or physical properties (liquid bandages A61L26/00) - A61L 15/44: Medicaments - A61L 15/58: Adhesives - A61L 26/0061: {Use of materials characterised by their function or physical properties} - A61L 26/0066: {Medicaments; Biocides} - A61L 2300/22: Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes - A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents - A61L 2300/406: Antibiotics - A61L 2300/428: Vitamins, e.g. tocopherol, riboflavin - A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K) ## Abstract A wound management system can comprise a surgically acceptable adhesive disposed over a wound and a surgically acceptable film repositionably disposed over the surgically acceptable adhesive, and methods of managing a wound involving the same. ## Claims ### Claim 1 A wound management system, comprising a surgically acceptable cyanoacrylate skin adhesive disposed over and in direct contact with a wound; and a surgically acceptable film disposed over the surgically acceptable skin adhesive, wherein the surgically acceptable film is in contact with and repositionably binds to a cured surgically acceptable skin adhesive when the surgically acceptable skin adhesive is in direct contact with the wound, and wherein both the surgically acceptable cyanoacrylate skin adhesive and the surgically acceptable film cover the wound. ### Claim 2 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable skin adhesive comprises at least one of butylcyanoacrylate and octylcyanoacrylate. ### Claim 3 (depends on 2) The wound management system of claim 2, wherein the surgically acceptable adhesive comprises octylcyanoacrylate. ### Claim 4 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film comprises a first side and a second side, the first side having a pressure sensitive adhesive disposed thereon. ### Claim 5 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film comprises a silicone sheet. ### Claim 6 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film comprises a silicone adhesive. ### Claim 7 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is formed by disposing a curable gel or curable liquid over the surgically acceptable skin adhesive and curing the curable gel or curable liquid into a film. ### Claim 8 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is permeable to at least one of air, moisture, blood, and wound exudate. ### Claim 9 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is semi-permeable to at least one of air, moisture, blood, and wound exudate. ### Claim 10 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is impermeable to at least one of air, moisture, blood, and wound exudate. ### Claim 11 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is transparent or translucent. ### Claim 12 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is opaque. ### Claim 13 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is adapted to change from transparent or translucent to opaque. ### Claim 14 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is in the form of a surgically acceptable tape, dressing or bandage. ### Claim 15 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable adhesive is an atraumatic adhesive. ### Claim 16 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film comprises one or more of silicone, paper, cellulose, microporous material, polyamide, polyacrylate, polyester, copolyester, and fabric. ### Claim 17 (depends on 16) The wound management system of claim 16, wherein the surgically acceptable film comprises silicone. ### Claim 18 (depends on 17) The wound management system of claim 17, wherein the surgically acceptable film has a first surface comprising silicone and a second surface comprising one or more of paper, cellulose, microporous material, polyamide, polyacrylate, polyester, copolyester, and fabric. ### Claim 19 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is perforated. ### Claim 20 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film is not perforated. ### Claim 21 (depends on 1) The wound management system of claim 1, further comprising an absorbent dressing disposed over the surgically acceptable film. ### Claim 22 (depends on 1) The wound management system of claim 1, further comprising at least one topically administrable active agent. ### Claim 23 (depends on 22) The wound management system of claim 22, wherein the topically administrable active agent comprises one or more of antimicrobials, moisturizers, vitamins, skin nutrients, beneficial oils, and scar reducing agents. ### Claim 24 (depends on 1) The wound management system of claim 1, wherein the surgically acceptable film comprises one or more markings delineating one or more pre-determined shapes on the film. ### Claim 25 A method of managing a wound, comprising applying a surgically acceptable cyanoacrylate skin adhesive directly to a wound; and then applying a repositionable surgically acceptable film over the surgically acceptable skin adhesive wherein the surgically acceptable film is contacted with and bonds to the surgically acceptable skin adhesive, and wherein both the surgically acceptable cyanoacrylate skin adhesive and the surgically acceptable film cover the wound. ### Claim 26 (depends on 25) The method of claim 25, further comprising curing the surgically acceptable skin adhesive, wherein the cured skin adhesive does not impede the repositionability of the surgically acceptable film. ### Claim 27 (depends on 25) The method of claim 25, wherein the surgically acceptable skin adhesive comprises one or more of butylcyanoacrylate and octylcyanoacrylate. ### Claim 28 (depends on 25) The method of claim 25, wherein the surgically acceptable skin adhesive comprises octylcyanoacrylate. ### Claim 29 (depends on 25) The method of claim 25, wherein the repositionable surgically acceptable film is applied before the surgically acceptable skin adhesive is completely cured. ### Claim 30 (depends on 25) The method of claim 25, wherein the repositionable surgically acceptable film is applied after the surgically acceptable skin adhesive is completely cured. ### Claim 31 (depends on 25) The method of claim 25, wherein the repositionable surgically acceptable film is a surgically acceptable tape, dressing, or bandage. ### Claim 32 (depends on 25) The method of claim 25, wherein the surgically acceptable film is applied as a transparent or translucent film, and becomes opaque over time. ### Claim 33 (depends on 25) The method of claim 25, further comprising applying an absorbent dressing over the repositionable surgically acceptable film. ### Claim 34 (depends on 25) The method of claim 25, further comprising applying a topically acceptable active agent to the wound. ### Claim 35 (depends on 34) The method of claim 34, wherein the topically acceptable active agent includes one or more of anti-microbials, moisturizers, vitamins, skin nutrients, beneficial oils, and scar reducing agents. ### Claim 36 (depends on 25) The method of claim 25, wherein the surgically acceptable skin adhesive is applied from a sponge-tipped applicator, a high-density foam applicator, a flocked-tipped applicator, or a silicone-tipped applicator. ### Claim 37 (depends on 36) The method of claim 36, wherein the applicator is a blister-sealed applicator. ### Claim 38 (depends on 25) The method of claim 25, further comprising repositioning the repositionable surgically acceptable film after applying the repositionable surgically acceptable film.